A retrospective study of intravitreal bevacizumab (Avastin) in patients with neovascular glaucoma (NVG) who underwent Ahmed glaucoma valve (AGV) surgery.
Phase of Trial: Phase II
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Neovascular glaucoma
- Focus Therapeutic Use
- 03 Sep 2015 New trial record